A Single-Center, Open-Label, Fixed-Sequence Clinical Study to Evaluate the Pharmacokinetic Effects of Supaglutide on Digoxin or Metformin in Healthy Subjects

被引：0
|
作者：
He Jinjie
Zhang Jing
Anwar, Dilbar
Wu Haiya
Wang, Qinghua
Wu, Xiaojie
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-15-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tolerability and pharmacokinetics of disodium folinate following single intravenous doses in healthy Chinese subjects: an open-label, randomized, single-center study
    Liu, Yani
    Zhou, Jiali
    Li, Zhongfang
    Yang, Chunxiao
    Wu, Jianhong
    Zhang, Yu
    Shi, Shaojun
    Li, Yunqiao
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (04) : 443 - 451
  • [22] Tolerability and pharmacokinetics of disodium folinate following single intravenous doses in healthy Chinese subjects: an open-label, randomized, single-center study
    Yani Liu
    Jiali Zhou
    Zhongfang Li
    Chunxiao Yang
    Jianhong Wu
    Yu Zhang
    Shaojun Shi
    Yunqiao Li
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 443 - 451
  • [23] Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study
    Huang, Fenglei
    Marzin, Kristell
    Koenen, Ruediger
    Kammerer, Klaus Peter
    Strelkowa, Natalja
    Elgadi, Mabrouk
    Quinson, Anne-Marie
    Haertter, Sebastian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (10): : 1305 - 1314
  • [24] OPEN-LABEL, SINGLE-SEQUENCE STUDY OF THE EFFECTS OF KETOCONAZOLE ON THE PHARMACOKINETICS OF BMS-754807 IN HEALTHY SUBJECTS.
    Clemens, P. L.
    Park, J.
    Woolfson, A.
    Wang, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S39 - S40
  • [25] Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
    Rebecca E. Wrishko
    Jacqueline B. McCrea
    Ka Lai Yee
    Wen Liu
    Deborah Panebianco
    Eric Mangin
    Manu Chakravarthy
    Maria P. Martinez-Cantarin
    Walter K. Kraft
    Clinical Drug Investigation, 2019, 39 : 453 - 454
  • [26] A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, CROSSOVER STUDY TO EVALUATE THE INTERACTION OF MULTIPLE-DOSE ODEVIXIBAT WITH THE PHARMACOKINETICS OF SINGLE-DOSE COMBINED ORAL CONTRACEPTIVE STEROIDS IN HEALTHY FEMALE PARTICIPANTS
    Mazuir, Florent
    Ordonez, Claudia
    Wallefors, Terese
    Zhu, Judy
    Lindstrom, Erik
    HEPATOLOGY, 2024, 80 : S1773 - S1774
  • [27] A Single-center, Open-label, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of the Indirect Bonding Technique
    Murakami, Takashi
    Kawanabe, Noriaki
    Kataoka, Tomoki
    Hoshijima, Mitsuhiro
    Komori, Hiroki
    Fujisawa, Atsuro
    Kamioka, Hiroshi
    ACTA MEDICA OKAYAMA, 2016, 70 (05) : 413 - 416
  • [28] CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study
    Huang, Yunzhe
    Jia, Yuanwei
    Chen, Xinyan
    Wang, Changmao
    Wang, Yaqin
    Wang, Minhui
    Wu, Ping
    Shen, Jie
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (12) : 1005 - 1013
  • [29] A PHASE 1, RANDOMIZED, OPEN-LABEL, CROSSOVER, FIXED-SEQUENCE STUDY TO EVALUATE THE PK, DOSE-PROPORTIONALITY, BIOAVAILABILITY, AND TOLERABILITY OF SUBCUTANEOUS LEVOTHYROXINE SODIUM (XP-8121) IN HEALTHY ADULT SUBJECTS.
    Conoscenti, V.
    Huang, R.
    Fitch, R.
    Harper, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S84 - S84
  • [30] An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment
    Nakamaru, Yoshinobu
    Kakubari, Masae
    Yoshida, Kaori
    Akimoto, Makoto
    Kondo, Kazuoki
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1699 - 1714
12345